New deal
Silicozyme emerges from stealth, backed by BVP and LIOF, to make protein production simpler, lower-cost, and more scalable
16.07.2026
Our progress journal.
Portfolio
SHS Capital acquires majority stake in Basic Pharma
14.07.2026
Portfolio
Grassa wins Transition Award 2026 in the Food category
24.06.2026
Portfolio
Vivalyx wins Purpose and Impact Award at ODDO BHF Young Entrepreneurs Awards 2026
19.06.2026
Portfolio
Vertoro closes €17M Series B round to advance renewable oil platform to accelerate low-carbon fuels
17.06.2026
Portfolio
Honda uses Circularise to strengthen battery passport readiness ahead of 2027 EU requirements
10.06.2026
Portfolio
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
09.06.2026
Portfolio
Hy2Care selected for MedTech Innovator 2026 Accelerator Cohort
02.06.2026
Portfolio
Cell culture without animal serum: PL BioScience’s ELAREM validated in new Toxicology in Vitro study
01.06.2026
Portfolio
Stenting without X-rays: Nano4Imaging tools featured in new JACC study
21.05.2026
Portfolio
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
19.05.2026
Portfolio
Aliform wins MedTech World North America 2026 startup pitch competition
18.05.2026
Portfolio
niostem’s electrotrichogenic wearable device shows significant hair density gains in men with androgenetic alopecia
07.05.2026
Portfolio
Vivalyx announces First-in-Human use of Vivalyx Omnisol® in kidney transplant clinical trial
17.03.2026
Portfolio
Portfolio company Corporis Medical begins patient enrolment in clinical investigation of Laprixa
16.03.2026
Portfolio
Psylaris: bringing VR-powered trauma therapy to Ukraine
26.02.2026
Portfolio
PectCof (NL) secures a positive EFSA scientific opinion for Dutch Gum as a novel food ingredient
27.01.2026
Portfolio
Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229
11.12.2025
Portfolio
Lely invests in Dutch scale-up Grassa
09.12.2025
Portfolio
Exit: Fortimedix Surgical acquired by Medtronic
01.12.2025
Portfolio
Curapath and Cristal Therapeutics Sign Co-Exclusive License of CliCr® Bioconjugation Platform
26.11.2025
Portfolio
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
13.11.2025
Portfolio
Qorium secures €22m investment to accelerate cultivated leather commercialisation
11.11.2025
Portfolio
Matisse Pharmaceuticals & EpiDisease receive EU funding for their eHISTOCURE project
26.06.2025